- When you miss a dose, IOP begins rising silently. Repeated pressure spikes damage the optic nerve even when your clinic reading looks normal.
- Your specialist can only measure your IOP once per visit. They cannot see what happens on the nights you miss your drops.
- Feeling fine does not mean your pressure is stable. It means the drops are doing their job, or the damage has not yet crossed the point where you can notice it.
- If you want to use your glaucoma drops more consistently, make it a part of an existing nightly habit.
- If side effects or a difficult regimen are making you skip doses, tell your specialist in Singapore and they can suggest other glaucoma treatments that may suit you better.
It is 11pm. You are already in bed. The drops are in the bathroom and you cannot remember whether you used them or not. You decide it is probably fine and go to sleep.
For most medications, that would be fine. For glaucoma drops, it is the exact situation your specialist is worried about. Glaucoma causes no symptoms. When you miss doses, the pressure inside your eye rises silently, and any damage the optic nerve accumulates cannot be reversed.
The habit matters more than it feels like it does. Here is why, and what can make it easier.
Why Does Missing One Dose Put Your Optic Nerve at Risk?
The most common glaucoma drops prescribed by ophthalmologists belong to a class of medication called prostaglandin analogues. They work by continuously reducing intraocular pressure (IOP) by improving fluid outflow through the uveoscleral pathway, but only while they are active, which is why you need to take them every day (Cordeiro et al., 2024).
The problem is that nothing feels different when the pressure starts to rise on a night you skip a dose. Research confirms that these between-visit pressure spikes drive optic nerve damage faster, even in patients whose clinic readings looked normal (Nouri-Mahdavi et al., 2004).
The Real Reasons Glaucoma Patients Struggle With Their Drops
Most patients struggle with their drops for one of four reasons: glaucoma produces no symptoms so the urgency fades, doses are easy to forget, side effects make the drops uncomfortable to use, or the cost is difficult to manage. Each of these is addressable, but only if you raise it with your specialist.
No symptoms
The logic is intuitive but clinically incorrect: feeling fine is not evidence that your pressure is controlled. It is evidence that the drop is working, or that the nerve damage has not yet reached the threshold where you can perceive it. The sense of urgency that follows a diagnosis tends to fade once the condition stops feeling new, but the risk does not.
Forgetting
Side effects
Prostaglandin analogues can cause mild stinging, transient redness, and, with long-term use, gradual darkening of the iris and the skin around the eye (Alm et al., 2008). These effects are not dangerous, but they create low-level friction with every dose. If they are making you less likely to use the drops, tell your specialist. There are formulations and alternatives available.
Cost
Generic versions of many prostaglandin analogues are available and, in most cases, pharmacologically equivalent to branded versions (Czumbel et al., 2024). Ask your glaucoma specialist in Singapore whether a generic option is appropriate for your situation.
Any of these is worth raising at your next appointment rather than managing alone.
What to Watch For
- You regularly miss doses because the drops sting, cause redness, or irritate your eye
- Your IOP reading at a clinic appointment is higher than your previous visit, without explanation
- Your visual field test shows changes not present at an earlier assessment
- You are finding it difficult to afford your current prescription
- You have quietly reduced or stopped your drops without informing your specialist
Side effects that make you want to skip your drops are worth reporting, not tolerating. There are formulations and regimen changes that may be more appropriate for you. Talk to Angel Eye’s Dr Allan Fong about your options.
What Actually Helps You Remember Your Glaucoma Drops Every Night?
How to build a sustainable routine
- Habit stack your drops: Your drops should not be a separate task. Pair them with an existing routine so remembering, and doing, becomes automatic.
- Make the bottle visible: Place it on the bathroom counter next to your toothbrush so the decision is made before you are tired.
- Set a named alarm: Label it “glaucoma drops, bedtime” rather than a generic reminder. A specific label removes the moment of deciding what the alarm means.
- Track each dose: A calendar tick-off or dosing record app gives you a visual streak to maintain.
- Tell someone you trust: Asking a household member to check in is not a burden. It is a shared investment in your sight.
Managing side effects to stay on glaucoma treatment
Side effects can be reduced without a change in medication. After applying your drops, pressing the inner corner of the eye gently with a fingertip for 60 seconds, a technique called nasolacrimal occlusion, reduces how much medication your body absorbs and lessens local irritation (Müller et al., 2020).
If surface irritation is a persistent problem, ask your glaucoma specialist whether a preservative-free formulation is available for your drops. These are not available for all medications, but for patients with sensitive eyes, the difference in tolerability can be meaningful.
When Should You Consider Laser or Surgery for Glaucoma?
You should consider laser or surgery when drops are not adequately controlling your IOP, or when staying on them long-term has become genuinely difficult.
Selective Laser Trabeculoplasty (SLT) is an in-clinic procedure that uses targeted laser energy to improve drainage through the trabecular meshwork (the eye’s natural drainage tissue). It can serve as a primary treatment or alongside drops to reduce the medication burden. The LiGHT trial found that repeat SLT maintained drop-free IOP control in 67% of eyes at 18 months, and effects may persist for several years, though individual outcomes vary (Garg, Vickerstaff, Gazzard et al., 2020).
Minimally Invasive Glaucoma Surgery (MIGS) refers to a group of procedures that improve drainage with a lower risk profile than traditional surgery. These options are increasingly available as part of glaucoma treatment in Singapore and are sometimes performed alongside cataract surgery in eligible patients, meaning a single procedure can address both conditions.
Trabeculectomy is the more established surgical option for cases where IOP cannot be controlled through other means. It carries a higher risk profile than MIGS and requires a more extended recovery period, and is typically considered when other treatments have not achieved the target IOP.
Not sure whether your current drops are keeping your IOP where it needs to be? Book a comprehensive glaucoma assessment to explore other glaucoma treatments.
What to Watch For
- Your IOP remains elevated at consecutive clinic visits despite using your drops consistently
- Your visual field test shows continued changes despite treatment
- You have tried regimen adjustments but still struggle to stay on your drops long-term
- Your specialist has mentioned that your current treatment is not reaching your target IOP
Arrange a Glaucoma Review at Angel Eye & Cataract Centre
If you have been finding it difficult to stay on your glaucoma drops, or if you want to review whether your glaucoma treatment in Singapore is adequately controlling your IOP, a comprehensive glaucoma assessment at Angel Eye & Cataract Centre covers IOP measurement, optic nerve examination, visual field testing, and OCT imaging to give you a clear picture of where things stand and what your options are.
Dr Allan Fong is a Senior Consultant Eye Surgeon and Medical Director at Angel Eye & Cataract Centre, with over 26 years of experience in ophthalmology, and the former Head of the Cataract & Comprehensive Ophthalmology Department at Singapore National Eye Centre (SNEC).
Medical References
- Nouri-Mahdavi, K., Hoffman, D., Coleman, A.L., et al. (2004). Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology, 111(9), 1627–1635. DOI: 10.1016/j.ophtha.2004.02.017
- Cordeiro, M.F., Gandolfi, S., Gugleta, K., et al. (2024). How latanoprost changed glaucoma management. Acta Ophthalmologica, 102(2), e140–e155. PMID: 37350260. DOI: 10.1111/aos.15725
- Alm, A., Grierson, I., & Shields, M.B. (2008). Side effects associated with prostaglandin analog therapy. Survey of Ophthalmology, 53(Suppl 1), S93–105. PMID: 19038628. DOI: 10.1016/j.survophthal.2008.08.004
- Czumbel, N., Acs, T., Bator, G., et al. (2024). Phase III non-inferiority trial: generic preservative-free latanoprost vs Xalatan in ocular hypertension or primary open-angle glaucoma. BMC Ophthalmology, 24(1), 313. PMID: 39075412. DOI: 10.1186/s12886-024-03579-3
- Müller, L., Jensen, B.P., Bachmann, L.M., et al. (2020). New technique to reduce systemic side effects of timolol eye drops: The tissue press method. Clinical and Experimental Ophthalmology, 48(1), 24–30. PMID: 31525271. DOI: 10.1111/ceo.13642
- Garg, A., Vickerstaff, V., Nathwani, N., Gazzard, G., et al. (2020). Efficacy of repeat selective laser trabeculoplasty in medication-naive open-angle glaucoma and ocular hypertension during the LiGHT Trial. Ophthalmology, 127(4), 467–476. PMID: 32005561. DOI: 10.1016/j.ophtha.2019.10.023
- National Eye Institute. (2023). Glaucoma. nei.nih.gov
- World Health Organisation. (2023). Blindness and vision impairment. who.int
